ARCA Biopharma Inc (NASDAQ:ABIO)
| 1.43 Data as of Jul 31 |  +0.0099 / +0.70%Today’s Change | 1.19 Today|||52-Week Range 2.54 | -14.89% Year-to-Date |
Latest ABIO News | Press Releases
No recent news for ARCA Biopharma Inc.
Today’s Trading
| Previous close | 1.42 |
| Today’s open | 1.41 |
| Day’s range | 1.40 - 1.44 |
| Volume | 74,733 |
| Average volume (3 months) | 229,115 |
| Market cap | $29.8M |
| Dividend yield | -- |
Data as of 3:54pm ET, 07/31/2014
Growth & Valuation
| Earnings growth (last year) | +46.39% |
| Earnings growth (this year) | +52.88% |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.43 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| REPCFRepliCel Life Scienc... | 0.00 | 0.00% |
| RGDXResponse Genetics In... | -0.00 | -0.60% |
| ASMBAssembly Biosciences... | -0.23 | -3.51% |
| CLTXCelsus Therapeutics ... | +0.00 | +0.09% |
Data as of 4:00pm ET, 07/31/2014
Financials
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$6.9M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Michael R. Bristow |
Chief Financial Officer Patrick M. Wheeler |
Corporate headquarters Westminster, Colorado |
Forecasts
